• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 3. Achieving molecular stability of racemic 4-O-benzyl-myo-inositol-1,3,5-orthoformate through crystal formation?
  Richa Sardessai,Shobhana Krishnaswamy,Mysore S. Shashidhar CrystEngComm, 2012,14, 8010-8016
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. Achieving excellent anti-corrosion and tribological performance by tailoring the surface morphology and chemical composition of aluminum alloys
  Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Quaternary ammonium salts

Research Brief on 2-Methylhex-5-en-2-amine Hydrochloride (CAS: 1629136-35-1): Recent Advances and Applications

2-Methylhex-5-en-2-amine hydrochloride (CAS: 1629136-35-1) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have highlighted its potential as a versatile intermediate in the synthesis of bioactive molecules and its role in modulating biological pathways. This research brief consolidates the latest findings on this compound, focusing on its synthesis, pharmacological properties, and emerging applications in drug discovery.

Recent publications have explored the synthetic routes to 2-methylhex-5-en-2-amine hydrochloride, emphasizing its efficient production through catalytic hydrogenation and amine protection-deprotection strategies. The compound's structural features, including its unsaturated hydrocarbon chain and amine functionality, make it a valuable scaffold for designing novel drug candidates. Notably, its hydrochloride salt form enhances solubility and stability, which is critical for pharmaceutical formulations.

In pharmacological studies, 2-methylhex-5-en-2-amine hydrochloride has demonstrated promising activity in modulating neurotransmitter systems, particularly as a potential ligand for G-protein-coupled receptors (GPCRs). Preliminary in vitro assays indicate its affinity for serotonin and dopamine receptors, suggesting applications in neuropharmacology. Additionally, its role as a building block for synthesizing more complex molecules, such as kinase inhibitors and antimicrobial agents, has been investigated in recent patent filings.

One of the most significant advancements is the compound's application in targeted drug delivery systems. Researchers have functionalized 2-methylhex-5-en-2-amine hydrochloride to create pH-sensitive prodrugs, which release active therapeutics in specific physiological environments. This approach has shown efficacy in reducing off-target effects and improving therapeutic indices in preclinical models of cancer and inflammatory diseases.

Despite these promising developments, challenges remain in optimizing the compound's pharmacokinetic profile and minimizing potential side effects. Ongoing research aims to address these limitations through structural modifications and formulation improvements. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these findings into clinical applications.

In conclusion, 2-methylhex-5-en-2-amine hydrochloride (CAS: 1629136-35-1) represents a compelling area of research with broad implications for drug development. Its multifunctional properties and adaptability in synthetic chemistry position it as a key player in the next generation of therapeutic agents. Future studies will likely focus on expanding its utility in precision medicine and exploring its mechanisms of action at the molecular level.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)